About the grantee

Serwanga's leadership in immune profiling and monoclonal antibody discovery, funded by GIISER, has led to the identification of biomarkers of protection and the development of robust virus-specific antibody assays. Her work with 10x Genomics has revolutionized the understanding of the molecular mechanisms underpinning immune response, and her contributions to COVID-19 vaccine research have positioned UVRI as a central hub for epidemic preparedness. She is dedicated to the mentorship of emerging scientists and fostering international collaborations in the fight against global epidemics and viral diseases.